FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rodger MacArthur

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1
HIV

Procedures

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Rodger D MacArthur
Overview of the XIX International AIDS Conference.
Rodger D MacArthur; Herbert L DuPont
Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.
Nisha Andany; Janet Raboud; Sharon Walmsley; Christina Diong; Sean B Rourke; Sergio Rueda; Anita Rachlis; Wendy Wobeser; Rodger D MacArthur; Louise Binder; Ron Rosenes; Mona R Loutfy
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rodger MacArthur (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rodger D MacArthur
Overview of the XIX International AIDS Conference.
Current infectious disease reports 2013;15(1):1-3.
2012: Rodger D MacArthur; Herbert L DuPont
Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(6):860-7.
2011: Nisha Andany; Janet Raboud; Sharon Walmsley; Christina Diong; Sean B Rourke; Sergio Rueda; Anita Rachlis; Wendy Wobeser; Rodger D MacArthur; Louise Binder; Ron Rosenes; Mona R Loutfy
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada.
HIV clinical trials 2011;12(2):89-103.
2011: Rodger D MacArthur
Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients.
Current infectious disease reports 2011;13(1):1-3.
2010: Rodger D MacArthur
Instantaneous inhibitory potential and inhibitory quotient show a modest association with virologic outcome: is either a useful surrogate for clinical drug efficacy?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(1):99-100.
2010: Thomas P Giordano; Glenn Bartsch; Yafeng Zhang; Ellen Tedaldi; Judith Absalon; Sharon Mannheimer; Avis Thomas; Rodger D MacArthur
Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.
AIDS patient care and STDs 2010;24(5):287-95.
2010: Edward M Gardner; Katherine H Hullsiek; Edward Telzak; Shweta Sharma; Grace Peng; William Burman; Rodger D MacArthur; Margaret A Chesney; Gerald Friedland; Sharon B Mannheimer
Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.
AIDS (London, England) 2010;24(3):395-403.
2010: Geetha Sivasubramanian; Emmanuel Frempong-Manso; Rodger D MacArthur
Abacavir/lamivudine combination in the treatment of HIV: a review.
Therapeutics and clinical risk management 2010;6():83-94.
2010: Alice Tseng; Rodger D MacArthur
Profile of etravirine for the treatment of HIV infection.
Therapeutics and clinical risk management 2010;6():49-58.
2009: Rodger D MacArthur
Understanding HIV phenotypic resistance testing: usefulness in managing treatment-experienced patients.
AIDS reviews 2009;11(4):223-30.
2009: Christine A Hughes; Linda Robinson; Alice Tseng; Rodger D MacArthur
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir.
Expert opinion on pharmacotherapy 2009;10(15):2445-66.
2009: Birgitte Simen; Jan Fredrik Simons; Katherine Huppler Hullsiek; Richard M Novak; Rodger D MacArthur; John D Baxter; Chunli Huang; Christine Lubeski; Gregory S Turenchalk; Michael S Braverman; Brian Desany; Jonathan M Rothberg; Michael Egholm; Michael J Kozal
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
The Journal of infectious diseases 2009;199(5):693-701.
2008: Mary van den Berg-Wolf; Katherine Huppler Hullsiek; Grace Peng; Michael J Kozal; Richard M Novak; Li Chen; Lawrence R Crane; Rodger D MacArthur
Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons.
HIV clinical trials 2008;9(5):324-36.
2008: Jason V Baker; Grace Peng; Joshua Rapkin; David Krason; Cavan Reilly; Winston P Cavert; Donald I Abrams; Rodger D MacArthur; Keith Henry; James D Neaton
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
Journal of acquired immune deficiency syndromes (1999) 2008;48(5):541-6.
2008: Rodger D MacArthur; Richard M Novak
Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(2):236-41.
2008: Jason V Baker; Grace Peng; Joshua Rapkin; Donald I Abrams; Michael J Silverberg; Rodger D MacArthur; Winston P Cavert; W Keith Henry; James D Neaton
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.
AIDS (London, England) 2008;22(7):841-8.
2008: Sharon B Mannheimer; Nicholas Wold; Edward M Gardner; Edward Telzak; Katherine Huppler Hullsiek; Margaret A Chesney; Albert W Wu; Rodger D MacArthur; John P Matts; Gerald Friedland
Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(6):941-5.
2008: Edward M Gardner; Shweta Sharma; Grace Peng; Katherine Huppler Hullsiek; William Burman; Rodger D MacArthur; Margaret A Chesney; Edward Telzak; Gerald Friedland; Sharon B Mannheimer
Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.
AIDS (London, England) 2008;22(1):75-82.
2007: Michael J Kozal; Katherine Huppler Hullsiek; Rodger D MacArthur; Mary van den Berg-Wolf; Grace Peng; Ying Xiang; John D Baxter; Jonathan Uy; Edward Telzak; Richard M Novak
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies.
HIV clinical trials 2007;8(6):357-70.
2007: Ying Hao; Feng Lin; Rodger D MacArthur; Jonathan A Cohn; Daniel Barth-Jones; Hong Ye; Lawrence R Crane
A self-learning fuzzy discrete event system for HIV/AIDS treatment regimen selection.
IEEE transactions on systems, man, and cybernetics. Part B, Cybernetics : a publication of the IEEE Systems, Man, and Cybernetics Society 2007;37(4):966-79.
2007: Rodger D MacArthur
Darunavir: promising initial results.
Lancet 2007;369(9568):1143-4.
2006: Rodger D MacArthur; Richard M Novak; Grace Peng; Li Chen; Ying Xiang; Katherine Huppler Hullsiek; Michael J Kozal; Mary van den Berg-Wolf; Christopher Henely; Barry Schmetter; Marjorie Dehlinger
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
Lancet 2006;368(9553):2125-35.
2006: Ying Hao; Feng Lin; Rodger D MacArthur; Jonathan A Cohn; Daniel Barth-Jones; Hong Ye; Lawrence R Crane
A fuzzy discrete event system approach to determining optimal HIV/AIDS treatment regimens.
IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society 2006;10(4):663-76.
2006: Michael J Kozal; Katherine Huppler Hullsiek; Robert Leduc; Richard M Novak; Rodger D MacArthur; Jody Lawrence; John D Baxter
Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.
Antiviral therapy 2006;11(4):457-63.
2005: Hossein Salimnia; Ellen C Moore; Lawrence R Crane; Rodger D MacArthur; Marilynn R Fairfax
Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes.
Journal of clinical microbiology 2005;43(9):4635-9.
2005: Rodger D MacArthur; George Perez; Sharon Walmsley; John D Baxter; Christopher M Mullin; James D Neaton
Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
HIV clinical trials 2005;6(3):127-35.
2005: Richard M Novak; Li Chen; Rodger D MacArthur; John D Baxter; Kathy Huppler Hullsiek; Grace Peng; Ying Xiang; Christopher Henely; Barry Schmetter; Jonathan Uy; Mary van den Berg-Wolf; Michael J Kozal
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(3):468-74.
2004: Rodger D MacArthur; Li Chen; Grace Peng; Richard M Novak; Mary van den Berg-Wolf; Michael J Kozal; L Besch; TM Yurik; Barry Schmetter; C Henley; M Dehlinger
Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.
HIV clinical trials 2004;5(6):361-70.
2004: Edward A Panacek; John C Marshall; Timothy E Albertson; David H Johnson; Steven B Johnson; Rodger D MacArthur; Mark Miller; William T Barchuk; Steven Fischkoff; Martin Kaul; Leah Teoh; Lori Van Meter; Lothar Daum; Stanley Lemeshow; Gregory Hicklin; Christopher Doig
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
Critical care medicine 2004;32(11):2173-82.
2004: Rodger D MacArthur
An updated guide to genotype interpretation.
The AIDS reader 2004;14(5):256-8, 261-4, 266.
2004: Paul Bayardelle; Timothy E Albertson; Rodger D MacArthur
Antibody to enterobacterial common antigen and gram-negative sepsis.
Critical care medicine 2004;32(2):617-8.
2004: Rodger D MacArthur; Mark Miller; Timothy E Albertson; Edward A Panacek; David Johnson; Leah Teoh; William Barchuk
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(2):284-8.
2004: George Perez; Rodger D MacArthur; Sharon Walmsley; John A Baxter; Christopher M Mullin; James D Neaton
A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102).
HIV clinical trials 2004;5(1):7-18.
2003: Frank A Baciewicz; Rodger D MacArthur; Lawrence R Crane
Repair type I aortic dissection in a patient with human immunodeficiency virus infection.
The Annals of thoracic surgery 2003;76(3):917-9.
2003: Timothy E Albertson; Edward A Panacek; Rodger D MacArthur; Steven B Johnson; Ernest Benjamin; George M Matuschak; Gary P Zaloga; Dennis G Maki; Jeffrey Silverstein; Jeffrey K Tobias; Kathy Haenftling; George Black; J Wayne Cowens
Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
Critical care medicine 2003;31(2):419-27.
2003: William M O'Neil; Robert K Drobitch; Rodger D MacArthur; Marti J Farrough; Lawrence R Crane; Craig K Svensson
Beta-glucuronidase activity in patients infected with HIV.
AIDS (London, England) 2003;17(2):269-70.
2002: Thomas J Birk; Rodger D MacArthur; Lynn M Lipton; Sheldon D Levine
Aerobic exercise training fails to lower hypertriglyceridemia levels in persons with advanced HIV-1 infection.
The Journal of the Association of Nurses in AIDS Care : JANAC 2002;13(6):20-4.
2002: William M O'Neil; Rodger D MacArthur; Marti J Farrough; Mark A Doll; Adrian J Fretland; David W Hein; Lawrence R Crane; Craig K Svensson
Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.
Journal of clinical pharmacology 2002;42(6):613-9.
2001: Rodger D MacArthur; Li Chen; D L Mayers; C L Besch; Raymond F Novak; Mary van den Berg-Wolf; TM Yurik; Grace Peng; Barry Schmetter; B Brizz; D Abrams
The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial.
Controlled clinical trials 2001;22(2):176-90.
2000: Rodger D MacArthur
Drug resistance. An updated, user-friendly guide to genotype interpretation.
The AIDS reader 2000;10(11):652-7.
2000: Thomas J Birk; Angele V McGrady; Rodger D MacArthur; S Khuder
The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus.
Journal of alternative and complementary medicine (New York, N.Y.) 2000;6(5):405-14.
2000: Rodger D MacArthur
Antiretroviral therapy. Sequencing antiretrovirals.
The AIDS reader 2000;10(6):359-64.
2000: V Kak; Rodger D MacArthur; Lawrence R Crane
Treatment of HIV disease in the new millennium.
Seminars in thoracic and cardiovascular surgery 2000;12(2):140-4.
2000: J A Hidalgo; Rodger D MacArthur; Lawrence R Crane
An overview of HIV infection and AIDS: etiology, pathogenesis, diagnosis, epidemiology, and occupational exposure.
Seminars in thoracic and cardiovascular surgery 2000;12(2):130-9.
2000: Rodger D MacArthur; Michael M Lederman; Constance A Benson; Miriam Chernoff; Rob Roy MacGregor; John Spritzler; Laura F Mahon; Belinda Yen-Lieberman; SF Purvis
Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853.
The Journal of infectious diseases 2000;181(4):1486-90.
2000: William M O'Neil; Robert K Drobitch; Rodger D MacArthur; Marti J Farrough; Mark A Doll; Adrian J Fretland; David W Hein; Lawrence R Crane; Craig K Svensson
Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype.
Pharmacogenetics 2000;10(2):171-82.
1999: Timothy P Reilly; Rodger D MacArthur; Marti J Farrough; Lawrence R Crane; Patrick M Woster; Craig K Svensson
Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
The Journal of pharmacology and experimental therapeutics 1999;291(3):1356-64.
1999: Mark Steven Dworkin; Sullivan Patrick; Susan E Buskin; Robert D Harrington; J Olliffe; Rodger D MacArthur; C E Lopez
Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(5):1095-9.
1995: Joseph J Eron; S L Benoit; J Jemsek; Rodger D MacArthur; J Santana; J B Quinn; Daniel R Kuritzkes; M A Fallon; M Rubin
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.
The New England journal of medicine 1995;333(25):1662-9.
1995: Vincent F Mauro; L R Jacobs; L S Mauro; Rodger D MacArthur; D B White
Comparison of tobramycin pharmacokinetics after administration by CRIS and a traditional intravenous piggyback infusion.
The Annals of pharmacotherapy 1995;29(5):465-9.
1994: Spotswood L Spruance; Andrew T Pavia; D Peterson; A Berry; Richard B Pollard; Thomas Patterson; I Frank; S C Remick; M Thompson; Rodger D MacArthur; G E Morey; C H Ramirez-Ronda; B M Bernstein; D E Sweet; Lawrence R Crane; E A Peterson; C T Pachucki; S L Green; J Brand; A Rios; LM Dunkle; Anne Cross; M J Brown; P Ingraham; R Gugliotti; A H Schindzielorz; L Smaldone
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.
Annals of internal medicine 1994;120(5):360-8.
1994: Haig Donabedian; E O'Donnell; C Olszewski; Rodger D MacArthur; N Budd
Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient.
Diagnostic microbiology and infectious disease 1994;18(2):111-5.
1993: Rodger D MacArthur; S D Levine; Thomas J Birk
Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons.
Medicine and science in sports and exercise 1993;25(6):684-8.
1990: Rodger D MacArthur
Branhamella catarrhalis peritonitis in two continuous ambulatory peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1990;10(2):169-71.
1988: Rodger D MacArthur; M H Lehman; C A Currie-McCumber; David M Shlaes
The epidemiology of gentamicin-resistant Pseudomonas aeruginosa on an intermediate care unit.
American journal of epidemiology 1988;128(4):821-7.
1984: Rodger D MacArthur; V Lolans; Fred A. Zar; G G Jackson
Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic.
The Journal of infectious diseases 1984;150(5):778-9.
1984: Rodger D MacArthur; G G Jackson
An evaluation of the use of statistical methodology in the Journal of Infectious Diseases.
The Journal of infectious diseases 1984;149(3):349-54.
1982: Rodger D MacArthur; R Sekuler
Alcohol and motion perception.
Perception & psychophysics 1982;31(5):502-5.
1977: R Sekuler; Rodger D MacArthur
Alcohol retards visual recovery from glare by hampering target acquisition.
Nature 1977;270(5636):428-9.